Publication | Closed Access

CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome

ThrombosisCardiovascular DiseasePlatelet ResponseBlood PlateletHematologyBleeding RiskAcute Coronary SyndromePublic HealthPlatelet AntagonistMedicineCardiologyEpidemiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction